Olipudase alfa 20mg powder for solution for infusion vials
- SNOMED code
41346111000001109- Active compound
- Olipudase alfa
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Olipudase alfa
— 20 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Xenpozyme 20mg powder for concentrate for solution for infusion vials (Sanofi)
in short Xenpozyme 20mg pdr for concentrate for inf vials
Xenpozyme 20mg powder for concentrate for solution for infusion vials
- SNOMED code
41345111000001103- Supplier
- Sanofi
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Xenpozyme 20mg powder for concentrate for solution for infusion vials (Sanofi) 1 vial41345211000001109 ref. pack | 💯 Available Legal category: POM | 50002836631575000283663058 | NHS Indicative Price £3,612 | • Hospital |
| — |
Reference packs
Olipudase alfa 20mg powder for solution for infusion vials 1 vial
- SNOMED code
41345011000001104- Quantity and unit
- 1 vial
- Packs